| James J Blount Iii, MD | |
|
128 Highland Pkwy, Suite 202, Picayune, MS 39466-5577 | |
| (601) 798-3989 | |
| (601) 798-5914 |
| Full Name | James J Blount Iii |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 128 Highland Pkwy, Picayune, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992793897 | NPI | - | NPPES |
| 0118379 | Medicaid | MS | |
| 1979694 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 15547 (Mississippi) | Primary |
| Entity Name | Highland Community Hospital Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275887499 PECOS PAC ID: 5193970523 Enrollment ID: O20130308000320 |
News Archive
Peter Ruben and his team of researchers have spent years studying why seemingly healthy patients with inherited cardiac arrhythmias can sometimes suddenly die during exercise.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 50 mg, 100 mg, 150mg, 200 mg, and 250mg strength armodafinil tablets prior to the expiration of patents owned by Cephalon France.
A first-of-its-kind study of more than 53,000 U.S. nuclear power workers has found that employees in the commercial nuclear industry are less likely than the general population to die from cancer or non-cancer diseases due, in large measure, to the so-called "healthy worker effect."
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on December 29, 2009, it received a written notice from the listing qualifications staff of the NASDAQ Stock Market ("NASDAQ") informing the Company that trading of the Company's common stock would be suspended prior to the open of business on January 4, 2010 and that NASDAQ would initiate procedures to delist the Company's common stock.
Researchers say that using the lower limit of normal of the forced expiration volume in 1 second/forced vital capacity ratio improves risk stratification in patients with chronic obstructive pulmonary disease undergoing thoracic surgery.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James J Blount Iii, MD 128 Highland Pkwy, Suite 202, Picayune, MS 39466-5577 Ph: (601) 798-3989 | James J Blount Iii, MD 128 Highland Pkwy, Suite 202, Picayune, MS 39466-5577 Ph: (601) 798-3989 |
News Archive
Peter Ruben and his team of researchers have spent years studying why seemingly healthy patients with inherited cardiac arrhythmias can sometimes suddenly die during exercise.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 50 mg, 100 mg, 150mg, 200 mg, and 250mg strength armodafinil tablets prior to the expiration of patents owned by Cephalon France.
A first-of-its-kind study of more than 53,000 U.S. nuclear power workers has found that employees in the commercial nuclear industry are less likely than the general population to die from cancer or non-cancer diseases due, in large measure, to the so-called "healthy worker effect."
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on December 29, 2009, it received a written notice from the listing qualifications staff of the NASDAQ Stock Market ("NASDAQ") informing the Company that trading of the Company's common stock would be suspended prior to the open of business on January 4, 2010 and that NASDAQ would initiate procedures to delist the Company's common stock.
Researchers say that using the lower limit of normal of the forced expiration volume in 1 second/forced vital capacity ratio improves risk stratification in patients with chronic obstructive pulmonary disease undergoing thoracic surgery.
› Verified 2 days ago
Dr. Eric Todd Siegel, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 128 Highland Pkwy Ste 202, Picayune, MS 39466 Phone: 601-358-9422 | |
Cynthia V Jean-pierre, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 128 Highland Pkwy, Suite 202, Picayune, MS 39466 Phone: 601-798-5798 Fax: 601-798-3964 |